You've lost me now apologies.
IMHO, good biotechs on asx are very slim pickings. Simcare may have done DD, but I would like to also.
My questions remain, anyone else have an answer?
Let's hope for GBM patients pax offers survival benefit.
GLTA.
Ann: Kazia releases final data from P2 paxalisib trial, page-103
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)